ClinicalTrials.govpublic full text
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
sleep initiation and maintenance disorders, mental disorders, dyssomnias, sleep disorders, sleep disorders, intrinsic, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828321
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.